XML Financial LLC reduced its position in CVS Health Co. (NYSE:CVS – Free Report) by 4.9% during the third quarter, Holdings Channel.com reports. The firm owned 80,251 shares of the pharmacy operator’s stock after selling 4,113 shares during the quarter. XML Financial LLC’s holdings in CVS Health were worth $5,046,000 as of its most recent SEC filing.
Other hedge funds have also bought and sold shares of the company. Livelsberger Financial Advisory bought a new stake in shares of CVS Health during the third quarter worth about $31,000. Crewe Advisors LLC acquired a new position in CVS Health during the 1st quarter valued at about $40,000. Reston Wealth Management LLC bought a new stake in CVS Health during the 3rd quarter worth approximately $32,000. Kathleen S. Wright Associates Inc. purchased a new stake in shares of CVS Health in the third quarter worth approximately $33,000. Finally, First Community Trust NA boosted its position in shares of CVS Health by 116.2% during the second quarter. First Community Trust NA now owns 562 shares of the pharmacy operator’s stock valued at $33,000 after buying an additional 302 shares during the last quarter. Institutional investors and hedge funds own 80.66% of the company’s stock.
CVS Health Trading Down 2.7 %
Shares of CVS Health stock opened at $55.54 on Friday. The company has a debt-to-equity ratio of 0.80, a quick ratio of 0.66 and a current ratio of 0.80. The stock has a market capitalization of $69.87 billion, a P/E ratio of 14.10, a P/E/G ratio of 0.94 and a beta of 0.55. CVS Health Co. has a 52-week low of $52.77 and a 52-week high of $83.25. The stock’s 50-day simple moving average is $59.56 and its 200 day simple moving average is $59.19.
CVS Health Announces Dividend
The business also recently disclosed a quarterly dividend, which was paid on Friday, November 1st. Investors of record on Monday, October 21st were paid a dividend of $0.665 per share. The ex-dividend date was Monday, October 21st. This represents a $2.66 dividend on an annualized basis and a dividend yield of 4.79%. CVS Health’s payout ratio is 67.51%.
Analysts Set New Price Targets
A number of research firms recently commented on CVS. Wells Fargo & Company lowered their price target on CVS Health from $61.00 to $60.00 and set an “equal weight” rating for the company in a research report on Monday, November 4th. Cantor Fitzgerald restated a “neutral” rating and set a $62.00 price target on shares of CVS Health in a report on Tuesday, October 1st. Evercore ISI upped their price objective on shares of CVS Health from $62.00 to $75.00 and gave the stock an “outperform” rating in a research report on Tuesday, October 8th. TD Cowen upgraded CVS Health from a “hold” rating to a “buy” rating and boosted their target price for the stock from $59.00 to $85.00 in a research note on Friday, October 4th. Finally, Mizuho decreased their price target on CVS Health from $73.00 to $66.00 and set an “outperform” rating for the company in a research report on Thursday, October 24th. Nine equities research analysts have rated the stock with a hold rating and twelve have given a buy rating to the company’s stock. According to MarketBeat, CVS Health presently has a consensus rating of “Moderate Buy” and an average target price of $73.00.
View Our Latest Research Report on CVS Health
CVS Health Company Profile
CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.
See Also
- Five stocks we like better than CVS Health
- Stock Market Holidays 2022-2025 – Here’s When the NYSE and NASDAQ Will be Closed
- Observability Wars: Datadog and Dynatrace Vie for Data Dominance
- Why is the Ex-Dividend Date Significant to Investors?
- Airbnb Stock Attracts Attention With Strong Cash Flow Strategy
- Insider Selling Explained: Can it Inform Your Investing Choices?
- MarketBeat Week in Review – 11/4 – 11/8
Want to see what other hedge funds are holding CVS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CVS Health Co. (NYSE:CVS – Free Report).
Receive News & Ratings for CVS Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVS Health and related companies with MarketBeat.com's FREE daily email newsletter.